Macro Group Pharmaceuticals (Macro Capital) S.A.E Share Price
Stocks
MCRO
EGS7D971C011
Pharmaceuticals
|
End-of-day quote
Egyptian Exchange
28/09/2026
|
5-day change | 1st Jan Change | ||
| 1.460 EGP | -2.01% |
|
-9.88% | +28.07% |
| 17/05 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 17/05 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 499.5Cr 9.59Cr 8.43Cr 7.97Cr 7.23Cr 14Cr 920.31Cr 14Cr 95Cr 37Cr 469.61Cr 36Cr 35Cr 1.51TCr | P/E 2026 * |
24.3x | P/E 2027 * | 16.2x |
|---|---|---|---|---|---|
| Enterprise Value | 491.53Cr 9.43Cr 8.3Cr 7.85Cr 7.12Cr 13Cr 905.63Cr 13Cr 94Cr 36Cr 462.12Cr 35Cr 35Cr 1.49TCr | EV / Sales 2026 * |
4.13x | EV / Sales 2027 * | 3.15x |
| Free-Float |
30.46% | Yield 2026 * |
2.05% | Yield 2027 * | 2.74% |
| 1 day | -2.01% | ||
| 1 week | -9.88% | ||
| Current month | -2.67% | ||
| 1 month | -2.67% | ||
| 3 months | +23.73% | ||
| 6 months | +5.80% | ||
| Current year | +28.07% |
| 1 week | 1.41 |  | 1.7 |
| 1 month | 1.41 | | 1.81 |
| Current year | 1.02 | | 1.81 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ahmed El-Nayeb
CHM | Chairman | - | 01/01/2002 |
Tamir Saeed
BRD | Director/Board Member | - | 01/01/2021 |
Norbert Lurz
BRD | Director/Board Member | - | 01/01/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.01% | -9.88% | -50.51% | -44.06% | 9.59Cr | |
| +0.11% | +1.71% | +63.52% | +117.61% | 1,05600Cr | |
| +0.27% | +0.92% | +51.33% | +73.35% | 66TCr | |
| +0.73% | +0.68% | +20.70% | +74.90% | 47TCr | |
| -1.35% | -3.32% | +37.45% | +40.55% | 34TCr | |
| -0.26% | +4.16% | +22.46% | +29.22% | 28TCr | |
| +0.50% | -0.63% | +13.56% | +13.42% | 26TCr | |
| +0.85% | +6.35% | +53.17% | +54.39% | 23TCr | |
| +0.85% | +1.10% | +35.78% | +101.82% | 19TCr | |
| +0.06% | -2.32% | -28.08% | -60.74% | 17TCr | |
| Average | -0.48% | -0.44% | +21.94% | +40.05% | 36.43TCr | |
| Weighted average by Cap. | -0.26% | +1.04% | +40.35% | +69.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 119Cr 2.28Cr 2.01Cr 1.9Cr 1.72Cr 3.24Cr 219.25Cr 3.25Cr 23Cr 8.78Cr 111.88Cr 8.58Cr 8.39Cr 359.52Cr | 155.2Cr 2.98Cr 2.62Cr 2.48Cr 2.25Cr 4.22Cr 285.95Cr 4.24Cr 30Cr 11Cr 145.91Cr 11Cr 11Cr 468.89Cr |
| Net income | 21Cr 39.54L 34.78L 32.88L 29.83L 56.01L 38Cr 56.34L 3.94Cr 1.52Cr 19Cr 1.48Cr 1.45Cr 62Cr | 28Cr 54.32L 47.77L 45.18L 40.98L 76.95L 52Cr 77.4L 5.41Cr 2.09Cr 27Cr 2.04Cr 2Cr 85Cr |
| Net Debt | -7.97Cr -15.3L -13.45L -12.72L -11.54L -21.67L -15Cr -21.8L -1.52Cr -58.83L -7.49Cr -57.43L -56.19L -24Cr | -11Cr -21.11L -18.57L -17.56L -15.93L -29.91L -20Cr -30.08L -2.1Cr -81.2L -10Cr -79.27L -77.55L -33Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | EGP 1.460 | -2.01% | 3,04,43,066 |
| 27/26/27 | EGP 1.490 | -6.29% | 2,54,27,091 |
| 24/26/24 | EGP 1.590 | -2.45% | 3,86,71,818 |
| 23/26/23 | EGP 1.630 | -2.98% | 2,31,93,515 |
| 22/26/22 | EGP 1.680 | +3.70% | 7,95,10,884 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.460EGP
Average target price
1.570EGP
Spread / Average Target
+7.53%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
Select your edition
All financial news and data tailored to specific country editions
